046210 — HLB PanaGene Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for HLB PanaGene Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	3,505	4,916	4,967	2,240	-5,538
Depreciation
Amortisation
Non-Cash Items	-3,121	408	-997	244	4,951
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	-669	-2,414	713	-337	-376
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,047	4,233	6,012	3,361	36.1
Capital Expenditures	-953	-425	-443	-362	-705
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	111	3,344	-4,643	-4,145	-54,993
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-842	2,919	-5,087	-4,506	-55,698
Financing Cash Flow Items	49.8	9.39	83.1	6.48	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	437	-18.4	6.47	-107	56,469
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	643	6,879	1,268	-1,164	805